Dec 22 (Reuters) - NeuBase Therapeutics Inc :
* NEUBASE THERAPEUTICS INC - CARNEGIE MELLON UNIVERSITY TERMINATED LICENSE AGREEMENT
* NEUBASE THERAPEUTICS INC - DID NOT INCUR ANY EARLY TERMINATION PENALTIES IN CONNECTION WITH THE TERMINATION OF THE LICENSE AGREEMENT
* NEUBASE THERAPEUTICS INC - CMU TERMINATED LICENSE AGREEMENT IN CONNECTION WITH EXCLUSIVE, WORLDWIDE RIGHT TO PATROL TECHNOLOGY
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments